| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K48477130 |
| PharmacoGx | BRD-K48477130 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CACNB4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | DENND6B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | EIF4E2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | SLC30A4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | TMF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | C14orf159 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | PREX2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | DGAT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | F8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PAX3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.07 |
